Stay updated on Johnson & Johnson Press Releases

Sign up to get notified when there's something new on the Johnson & Johnson Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Johnson & Johnson Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    The press releases listing was updated with new December 2025 entries (e.g., CARTITUDE-4 data, INLEXZO, Naomi Watts eye exam, Nipocalimab EC approval) and the total results count was adjusted.
    Difference
    8%
    Check dated 2025-12-07T13:45:49.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added two new press-release items: one emphasizes leadership in hematology and announces new paradigm-shifting research at ASH 2025. The second provides details on more than 60 abstracts and the MajesTEC-3 late-breaking presentation with pivotal PFS and OS results.
    Difference
    0.6%
    Check dated 2025-11-30T06:09:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added new press releases dated Nov 21, 2025 and Nov 17, 2025 (Auτonomy Study; TREMFYA data) and an acquisition of Halda Therapeutics; removed older items from Oct 28–31, 2025.
    Difference
    7%
    Check dated 2025-11-23T07:31:36.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    New press releases dated Nov 6–2, 2025 have been added (for example DARZALEX FASPRO FDA approval and CAPLYTA efficacy updates) and older items from Oct 24–27, 2025 have been removed, updating the current results shown on the page.
    Difference
    6%
    Check dated 2025-11-09T01:48:28.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    New press releases dated Oct 31–Oct 24, 2025 were added to the listing, expanding the current feed. Deletions remove older results and items as part of content curation.
    Difference
    8%
    Check dated 2025-11-01T21:10:26.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    New press releases and highlights have been added, including Nipocalimab, icotrokinra, and Impella updates. Older items such as the Orthopaedics separation announcement and detailed Q3 2025 financial results were removed.
    Difference
    8%
    Check dated 2025-10-25T19:24:58.000Z thumbnail image

Stay in the know with updates to Johnson & Johnson Press Releases

Enter your email address, and we'll notify you when there's something new on the Johnson & Johnson Press Releases page.